# Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

> **NCT00679523** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 60 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** AN2690 Solution, 5.0%
- **DRUG:** AN2690 Solution, 7.5%

## Key facts

- **NCT ID:** NCT00679523
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679523, "Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00679523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*